News und Analysen

If you're looking to get started with investing, there are many solid stocks you can put in your portfolio. Ideally, you'll want to start with some blue chip stocks to be pillars that you can hang

Want some good, cheap stocks to buy for the new year? The ones that I've listed below all trade below $100 a share, are cheap with respect to their earnings, and offer a mix of value, dividends, and

Last year was a rebound one for CVS Health (NYSE: CVS) and Amgen (NASDAQ: AMGN). After underperforming broader equities in 2024, both healthcare giants bounced back in 2025, outperforming the market

The healthcare sector underperformed broader equities in 2025, but that shouldn't deter investors. Many companies in the industry performed relatively well and appear to be solid buy-and-hold

A rising tide doesn't lift all boats. For example, a boat with gaping holes in its hull will sink regardless of how high the tide rises. Pfizer (NYSE: PFE) seemed to be the investing equivalent of

Shares of Super Micro Computer (NASDAQ: SMCI) sank 13.5% in December, according to data from S&P Global Market Intelligence. As an assembler of advanced computer chips for data center providers, the

In today's video, I discuss recent updates affecting Advanced Micro Devices (NASDAQ: AMD) and other AI stocks. To learn more, check out the short video, consider subscribing, and click the special

Over short periods, Wall Street is largely driven by emotions. When there's a compelling story, such as the emergence of GLP-1 weight loss drugs in the pharmaceutical sector, investors tend to

Did you know that in just the past three years, healthcare giant Pfizer (NYSE: PFE) has lost approximately half its value? The stock surged during the pandemic as its COVID-19 vaccine and pill

The beauty and wellness industry operates largely on an old-economy model in which manufacturers sell products wholesale to retailers that are then responsible for figuring out how best to sell

This is the time of year when market professionals and investors alike pore over lists of top analyst stock picks. One big company that appeared in such a lineup was UnitedHealth (NYSE: UNH), and in

Alumis (NASDAQ:ALMS), which develops targeted therapies for immune-mediated diseases, closed Tuesday’s session at $16.23, up 95.31%. Trading volume reached 64.1 million shares, coming in about

Stryker (NYSE: SYK) stock is hopping Tuesday morning, up 3.2% through 11:45 a.m. ET, after Raymond James analyst Jayson Bedford called the company "one of the highest quality stocks in large cap

Shares of AngioDynamics (NASDAQ: ANGO) were sinking 13.1% as of 11:02 a.m. ET. The sell-off came after the medical technology company announced its third-quarter results before the market open.

Nektar Therapeutics (NASDAQ: NKTR) was a big winner in 2025. The clinical-stage biotech saw its shares soar on positive clinical developments. Let's give credit where credit is due. Nektar's

Corey J Manley, EVP & Chief Legal/Admin Officer at Omnicell (NASDAQ:OMCL), executed an open-market sale of 6,106 shares for $243,629.40 on Dec. 3, 2025, as reported in the SEC Form 4 filing.

Thousands of stocks fly under most investors' radars, but that doesn't mean all of them are worthy of your attention. In an attempt to make it easier to narrow down the huge universe of stocks to

The average blue chip dividend stock's current yield is somewhere in the ballpark of 3% to 4%. Therefore, to see one paying out nearly 7% of its value is as suspicious as it is impressive.

When the

Dividend stocks can be a good strategy for investors seeking a reliable and potentially more predictable stream of passive income. Two companies with high dividend yields are the longtime automaker

UnitedHealth Group (NYSE: UNH) has long been one of the premier health insurance companies in the United States, but it and its stock are not unfamiliar with controversy or volatility. It's been a

In a challenging industry, Royal Caribbean Cruises (NYSE: RCL) has stood out for its exemplary returns for shareholders over the past five years. The first two articles in this three-part series

It might not seem like it, but the S&P 500 flirted with bear market territory earlier this year. It has rebounded nicely since, but it's always worth considering which stocks would be worth buying